SCHEMBL22978722

SCHEMBL22978722

CC(F)N1CCCC(N)C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2424015 0.83 DRD2 (0.36)
SCHEMBL22978687 0.83
SCHEMBL2424018 0.83 DRD2 (0.36)
SCHEMBL2424503 0.83 DRD2 (0.36)
Hydrochloric Acid SCHEMBL2429758 0.81 DRD2 (0.36)
Hydrochloric Acid SCHEMBL16054898 0.81 DRD2 (0.36)
Hydrochloric Acid SCHEMBL2423887 0.81 DRD2 (0.36)
SCHEMBL22778661 0.79
SCHEMBL22862916 0.79
SCHEMBL4842236 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed